Clinical trial
An Open-label, Multicenter, Pharmacokinetic Study of a FimH Blocker, EB8018, in Crohn's Disease Patients
NCT03709628 is registered in ClinicalTrials.gov with Enterome as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-label, Multicenter, Pharmacokinetic Study of a FimH Blocker, EB8018, in Crohn's Disease Patients
- Lead sponsor
- Enterome
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- March 7, 2018
- Completion date
- December 4, 2019
- Enrollment
- 8 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.